Jeff Johnson
Stock Analyst at Robert W. Baird
(4.52)
# 1,067
Out of 4,698 analysts
615
Total ratings
50.6%
Success rate
10.3%
Average return
Main Sectors:
Stocks Rated by Jeff Johnson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XRAY DENTSPLY SIRONA | Maintained: Hold | $14 → $15 | $11.38 | +31.81% | 54 | Aug 7, 2026 | |
| PODD Insulet | Maintained: Buy | $248 → $175 | $147.48 | +18.66% | 46 | Aug 6, 2026 | |
| ZBH Zimmer Biomet Holdings | Maintained: Hold | $92 → $104 | $98.07 | +6.05% | 38 | Aug 6, 2026 | |
| NVST Envista Holdings | Maintained: Buy | $31 → $34 | $27.28 | +24.63% | 38 | Aug 6, 2026 | |
| HSIC Henry Schein | Maintained: Buy | $97 → $109 | $89.81 | +21.37% | 57 | Aug 5, 2026 | |
| DXCM DexCom | Maintained: Buy | $80 → $105 | $87.90 | +19.45% | 61 | Jul 31, 2026 | |
| INMD InMode | Maintained: Hold | $14 → $17 | $14.91 | +14.02% | 39 | Jul 14, 2026 | |
| COO The Cooper Companies | Maintained: Buy | $98 → $85 | $69.59 | +22.14% | 55 | Jun 5, 2026 | |
| ENOV Enovis | Maintained: Buy | $45 → $37 | $18.56 | +99.35% | 15 | May 8, 2026 | |
| SWX: ALC Alcon Inc. | Maintained: Buy | CHF 76.95 → CHF 72.90 | CHF 57.30 | +27.23% | 33 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $437 → $385 | $303.13 | +27.01% | 37 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $28 → $14 | $19.42 | -27.91% | 7 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $205 → $218 | $158.64 | +37.42% | 66 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $18 → $30 | $19.90 | +50.75% | 60 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $47.80 | n/a | 1 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $67 | $3.32 | n/a | 1 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $42 → $49 | - | n/a | 6 | Dec 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $100.97 | n/a | 1 | Apr 11, 2016 |
DENTSPLY SIRONA
Aug 7, 2026
Maintained: Hold
Price Target: $14 → $15
Current: $11.38
Upside: +31.81%
Insulet
Aug 6, 2026
Maintained: Buy
Price Target: $248 → $175
Current: $147.48
Upside: +18.66%
Zimmer Biomet Holdings
Aug 6, 2026
Maintained: Hold
Price Target: $92 → $104
Current: $98.07
Upside: +6.05%
Envista Holdings
Aug 6, 2026
Maintained: Buy
Price Target: $31 → $34
Current: $27.28
Upside: +24.63%
Henry Schein
Aug 5, 2026
Maintained: Buy
Price Target: $97 → $109
Current: $89.81
Upside: +21.37%
DexCom
Jul 31, 2026
Maintained: Buy
Price Target: $80 → $105
Current: $87.90
Upside: +19.45%
InMode
Jul 14, 2026
Maintained: Hold
Price Target: $14 → $17
Current: $14.91
Upside: +14.02%
The Cooper Companies
Jun 5, 2026
Maintained: Buy
Price Target: $98 → $85
Current: $69.59
Upside: +22.14%
Enovis
May 8, 2026
Maintained: Buy
Price Target: $45 → $37
Current: $18.56
Upside: +99.35%
Alcon Inc.
May 7, 2026
Maintained: Buy
Price Target: CHF 76.95 → CHF 72.90
Current: CHF 57.30
Upside: +27.23%
May 1, 2026
Maintained: Buy
Price Target: $437 → $385
Current: $303.13
Upside: +27.01%
Feb 18, 2026
Maintained: Hold
Price Target: $28 → $14
Current: $19.42
Upside: -27.91%
Feb 5, 2026
Maintained: Buy
Price Target: $205 → $218
Current: $158.64
Upside: +37.42%
Dec 16, 2025
Upgraded: Buy
Price Target: $18 → $30
Current: $19.90
Upside: +50.75%
Dec 21, 2023
Reiterated: Buy
Price Target: n/a
Current: $47.80
Upside: n/a
May 5, 2023
Maintained: Buy
Price Target: $67
Current: $3.32
Upside: n/a
Dec 4, 2017
Reiterated: Hold
Price Target: $42 → $49
Current: -
Upside: n/a
Apr 11, 2016
Reiterated: Hold
Price Target: n/a
Current: $100.97
Upside: n/a